Methamphetamine modulates DC-SIGN expression by mature dendritic cells

Journal of Neuroimmune Pharmacology

Volumn 1, Issue 3, 2006, Pages 296-304

  Nair, Madhavan P N ^a   Mahajan, Supriya ^a   Sykes, Don ^a   Bapardekar, Meghana V ^a   Reynolds, Jessica L ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

DC SIGN; HIV 1; Mature dendritic cells; Methamphetamine

Indexed keywords

CD209 ANTIGEN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; CENTRAL STIMULANT AGENT; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; DOPAMINE 1 RECEPTOR; GLYCOPROTEIN GP 120; GP120 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; LECTIN; METHAMPHETAMINE; SMALL INTERFERING RNA;

BIOSYNTHESIS; CONFERENCE PAPER; DENDRITIC CELL; DRUG ANTAGONISM; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL ADHESION MOLECULES; CENTRAL NERVOUS SYSTEM STIMULANTS; DENDRITIC CELLS; FLOW CYTOMETRY; GENE EXPRESSION; HIV ENVELOPE PROTEIN GP120; HUMANS; LECTINS, C-TYPE; METHAMPHETAMINE; RECEPTORS, CELL SURFACE; RECEPTORS, DOPAMINE D1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 33747375438     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-006-9027-1     Document Type: Conference Paper

References (69)

1. Ali SF, Itzhak Y (1998) Effects of 7-nitroindazole, an NOS inhibitor on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in mice. Ann N Y Acad Sci 844:122-130
2. Anonymous (2005) HIV & drugs, Meth use develops stronger link to HIV risk. AIDS Policy Law 20:5
3. Banchereau J, Steinman RM (1998) DC and the control of immunity. Nature 392:245-252
4. Baribaud F, Pohlmann S, Doms RW (2001) The role of DC-SIGN and DC-SIGNR in HIV and SIV attachment, infection, and transmission. Virology 286:1-6
5. Bashirova AA, Geijtenbeek TB, van Duijnhoven GC, van Vliet SJ, Eilering JB, Martin MP, Wu L, Martin TD, Viebig N, Knolle PA, Kewal Ramani VN, van Kooyk Y, Carrington M (2001) A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med 193:671-678
6. Bashirova AA, Wu L, Cheng J, Martin TD, Martin MP, Benveniste RE, Lifson JD, Kewal Ramani VN, Hughes A, Carrington M (2003) Novel member of the CD209 (DC-SIGN) gene family in primates. J Virol 77:217-227
7. Berger DS (2004) Crystal methamphetamine and HIV - a catastrophe. Posit Aware 15:43-45
8. Boddiger D (2005) Metamphetamine use linked to rising HIV transmission. Lancet 365:1217-1218
9. Brettle RP, Chiswick A, Bell J, Busuttil A, Wilson A, Povey S, Leen CL (1997) Pre-AIDS deaths in HIV infection related to intravenous drug use. QJM 90:617-629
10. Chang L, Ernst T, Speck O, Grob CS (2005) Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am J Psychiatry 162(2):361-369
11. Chomczynski P, Saaci N (1987) Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-choloroform extraction. Anal Biochem 162:156-159
12. Chougnet C, Cohen SS, Kawamura T, Landay AL, Kessler HA, Thomas E, Blauvelt A, Shearer GM (1999) Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: implications for immunotherapy. J Immunol 163:1666-1673
13. Curtis BM, Scharnowske S, Watson AJ (1992) Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc Natl Acad Sci USA 89:8356-8360
14. Dauer M, Obermaier B, Herten J, Haerle C, Pohl K, Rothenfusser S, Schnurr M, Endres S, Eigler A (2003a) Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors. J Immunol 170:4069-4076
15. Dauer M, Pohl K, Obermaier B, Meskendahl T, Robe J, Schnurr M, Endres S, Eigler A (2003b) Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation. Immunology 110:38-47
16. Fanales-Belasio E, Moretti S, Nappi F, Barillari G, Micheletti F, Cafaro A, Ensoli B (2002) Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses. J Immunol 168:197-206
17. Folcik RM, Merrill JD, Li Y, Guo CJ, Douglas SD, Starr SE, Ho WZ (2001) HIV-1 infection of placental cord blood monocyte-derived dendritic cells. J Hematother Stem Cell Res 10:609-620
18. Frosch D, Shoptaw S, Huber A, Rawson RA, Ling W (1996) Sexual HIV risk among gay and bisexual male methamphetamine abusers. J Subst Abuse Treat 13:483-486
19. Geijtenbeek TB, Krooshoop DJ, Bleijs DA, van Vliet SJ, van Duijnhoven GC, Grabovsky V, Alon R, Figdor CG, van Kooyk Y (2000a) DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat Immunol 1:353-357
20. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, Kewal Ramani VN, Littman DR, Figdor CG, van Kooyk Y (2000b) DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100:587-597
21. Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, van Kooyk Y, Figdor CG (2000c) Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100:575-585
22. Geijtenbeek TB, Engering A, van Kooyk Y (2002) DC-SIGN, a C-type lectin on DC that unveils many aspects of dendritic cell biology. Leukoc Biol 71:921-931
23. Geijtenbeek TB, van Kooyk Y (2003) DC-SIGN: a novel HIV receptor on DCs that mediates HIV-1 transmission. Curr Top Microbiol Immunol 276:31-54
24. Gifford AN, Park MH, Kash TL, Herman LM, Park EH, Gatley SJ, Volkow ND (2000) Effect of amphetamine-induced dopamine release on radiotracer binding to D1 and D2 receptors in rat brain striatal slices. Naunyn Schmiedebergs Arch Pharmacol 362(4-5):413-418
25. Halkitis PN, Parsons JT, Stirratt MJ (2001) A double epidemic: crystal methamphetamine drug use in relations to HIV transmission among gay men. J Homosex 41:17-35
26. Halkitis PN, Fischgrund BN, Parsons JT (2005) Explanations for methamphetamine use among gay and bisexual men in New York City. Subst Use Misuse 40(9):1331-1345
27. Hart DN (1997) Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90:3245-3287
28. Hirshfield S, Remien RH, Humberstone M, Walavalkar I, Chiasson MA (2004) Substance use and high-risk sex among men who have sex with men: a national online study in the USA. AIDS Care 16:1036-1047
29. Kalechstein AD, Newton TF, Green M (2003) Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J Neuropsychiatry Clin Neurosci 15 (2):215-220
30. Kuribara H, Uchihashi Y (1994) Effects of dopamine antagonism on methamphetamine sensitization: evaluation by ambulatory activity in mice. Pharmacol Biochem Behav 47:101-106
31. Mahajan SD, Schwartz SA, Nair MP (2003) Immunological assays for chemokine detection in in-vitro culture of CNS cells. Biol Proced Online 5:90-102
32. Mahajan SD, Aalinkeel R, Reynolds JL, Nair BB, Fernandez SF, Schwartz SA (2005) Morphine exacerbates HIV-1 viral protein gp120 induced modulation of chemokine gene expression in U373 astrocytoma cells. Curr HIV Res 3(3):277-288
33. Mallon DF, Buck A, Reece JC, Crowe SM, Cameron PU (1999) Monocyte-derived dendritic cells as a model for the study of HIV-1 infection: productive infection and phenotypic changes during culture in human serum. Immunol Cell Biol 77:442-450
34. Markowitz M, Mohri H, Mehandru S, Shet A, Berry L, Kalyanaraman R, Kim A, Chung C, Jean-Pierre P, Horowitz A, La Mar M, Wrin T, Parkin N, Poles M, Petropoulos C, Mullen M, Boden D, Ho DD (2005) Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report. Lancet 365:1031-1038
35. Mori T, Ito S, Kita T, Sawaguchi T (2004) Effects of dopamine- and serotonin-related compounds on methamphetamine-induced self-injurious behavior in mice. J Pharmacol Sci 96:459-464
36. Munzar P, Goldberg SR (2000) Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology 143:209-216
37. Nair MPN, Pottathil R, Heimer EP, Schwartz SA (1988) Effect of HIV recombinant and synthetic peptides on human immunodeficiency virus proteins. I. Effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes. Proc Natl Acad Sci USA 85:6498-6502
38. Nair MPN, Mahajan S, Schwartz SA (2000) Immunomodulatory roles of heroin and HIV protein on nitric oxide production by brain microvascular endothelial cells. NIDA Res Monogr 181:85-86
39. Nair MP, Mahajan SD, Schwartz SA, Reynolds J, Whitney R, Bernstein Z, Chawda RP, Sykes D, Hewitt R, Hsiao CB (2005a) Cocaine modulates dendritic cell-specific C type intercellular adhesion molecule-3-grabbing nonintegrin expression by dendritic cells in HIV-1 patients. J Immunol 174:6617-6626
40. Nair MP, Reynolds JL, Mahajan SD, Schwartz SA, Aalinkeel R, Bindukumar B, Sykes D (2005b) RNAi-directed inhibition of DC-SIGN by dendritic cells: prospects for HIV-1 therapy. AAPS J 7(3):E572-E578
41. National Drug Threat Assessment (NDTA) Summary Report (2005) Methamphetamine. www.usdoj.gov/ndic/pubs11/13846/meth.htm
42. National Survey on Drug Use and Health (NSDUH) (2003) https://nsduhweb.rti.org/
43. National Institute of Drug Abuse (NIDA) INFO FACTS (2005) Methamphetamine. National Institute of Drug Abuse, Baltimore, May 2005.
44. Office of National Drug Control Policy (ONDCP) (2005) Drug facts. Office of National Drug Control Policy, Rockville, MD
45. Patterson S, Roberts MS, English NR, Macatonia SE, Gompels MN, Pinching AJ, Knight SC (1994) Detection of HIV DNA in peripheral blood dendritic cells of HIV-infected individuals. Res Virol 145:171-176
46. Pellegrino T, Bayer BM (1998) In vivo effects of cocaine on immune cell function. J Neuroimmunol 83:139-147
47. Piguet V, Blauvelt A (2002) Essential roles for DC in the pathogenesis and potential treatment of HIV disease. J Invest Dermatol 119:365-369
48. Pöhlmann SE, Soilleux J, Baribaud F, Leslie GJ, Morris LS, Trowsdale J, Lee B, Coleman N, Doms RW (2001a) DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and immunodeficiency viruses and activates infection in trans. Proc Natl Acad Sci USA 98:2670-2675
49. Pöhlmann S, Leslie G, Edwards TG, Macfarlan T, Reeves JD, Hiebenthal-Millow K, Kirchhoff F, Baribaud F, Doms RW (2001b) DC-SIGN interactions with human immunodeficiency virus: virus binding and transfer are dissociable functions. J Virol 75:10523-10526
50. Pöhlmann S, Baribaud F, Doms RW (2001c) DC-SIGN and DC-SIGNR: helping hands for HIV. Trends Immunol 22:643-646
51. Pubill D, Chipana C, Camins A, Pallas M, Camarasa J, Escubedo E (2005) Free radical production induced by methamphetamine in rat striatal synaptosomes. Toxicol Appl Pharmacol 204(1):57-68
52. Schepers RJF, Oyler JM, Joseph RE, Cone EJ, Moolchan ET, Huestis MA (2003) Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem 49:121-132
53. Shepard JD, Chuang DT, Shaham Y, Morales M (2006) Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat. Psychopharmacology (Berl) 185(4):505-513
54. Shibata S, Ono M, Fukuhara N, Watanabe S (1995) Involvement of dopamine, N-methyl-D-aspartate and sigma receptor mechanisms in methamphetamine-induced anticipatory activity rhythm in rats. J Pharmacol Exp Ther 274:688-694
55. Shively L, Chang L, LeBon JM, Liu Q, Riggs AD, Singer-Sam J (2003) Real-time PCR assay for quantitative mismatch detection. Biotechniques 34:498-502, 504
56. Sibley DR, Monsma FJ Jr, Shen Y (1993) Molecular neurobiology of dopaminergic receptors. Int Rev Neurobiol 35:391-415
57. Soilleux EJ, Barten R, Trowsdale J (2000) DC-SIGN; a related gene, DC-SIGNR; and CD23 form a cluster on 19p13. J Immunol 165:2937-2942
58. Steinman RM, Germain RN (1988) Antigen presentation and related immunological aspects of HIV-1 vaccines. AIDS 12SA:S97-S112
59. Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271-296
60. Steinman RM (2000) DC-SIGN: a guide to some mysteries of dendritic cells. Cell 100:491-494
61. Takayasu T, Ohshima T, Nishigami J, Kondo T, Nagaon T (1995) Screening and determination of methamphetamine and amphetamine in the blood, urine and stomach contents in emergency medical care and autopsy cases. J Clin Forensic Med 2:25-33
62. Tidey JW, Bergman J (1998) Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs. J Pharmacol Exp Ther 285:1163-1174
63. Toujas L, Delcros JG, Diez E, Gervois N, Semana G, Corradin G, Jotereau F (1997) Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptides. Immunology 91:635-642
64. Tsunetsugu-Yokota Y, Akagawa K, Kimoto H, Suzuki K, Iwasaki M, Yasuda S, Hausser G, Hultgren C, Meyerhans A, Takemori T (1995) Monocyte-derived cultured dendritic cells are susceptible to human immunodeficiency virus infection and transmit virus to resting T cells in the process of nominal antigen presentation. J Virol 69:4544-4547
65. Turville SG, Cameron PU, Handley A, Lin G, Pöhlmann S, Doms RW, Cunningham AL (2002) Diversity of receptors binding HIV on dendritic cell subsets. Nat Immunol 3(10):975-983
66. Urbina A, Jones K (2004) Crystal methamphetamine, its analogues, and HIV infection: medical and psychiatric aspects of a new epidemic. Clin Infect Dis 38:890-894
67. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN (2001a) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158(3):377-382
68. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N (2001b) Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158(12):2015-2021
69. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M, Gatley SJ, Miller E, Hitzemann R, Ding YS, Logan J (2001c) Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 21(23):9414-9418